Cardiovascular disease (CVD) is the leading cause of death in women, who have a notable
increase in the risk for this disease after menopause and typically develop coronary heart …

Objective: Our initial understanding of the menopause transition (MT) has been framed by
clinical samples of women seeking treatment rather than by population-based studies. The …

Importance Menopause, due to loss of ovarian follicular activity without another pathological
or physiological cause, typically occurs between the ages of 45 years and 56 years. During …

This care pathway from the European Menopause and Andropause Society (EMAS)
provides an updated pathway for monitoring and guidance of women at midlife, focusing on …

Abstract Study Objectives Polysomnography (PSG) is considered the “gold standard” for
assessing sleep, but cost and burden limit its use. Although wrist actigraphy and self-report …

There are 3 common physiological estrogens, of which estradiol (E2) is seen to decline
rapidly over the menopausal transition. This decline in E2 has been associated with a …

Perimenopause, or the menopausal transition, represents a period of time during which
newly arising symptoms can present complex management decisions for providers. Many …

Increasing numbers of women experience early menopause due in part to surgical treatment
for benign gynecologic disorders and the rise in risk-reducing bilateral salpingo …

Context The ovaries and adrenals are sources of androgens in women. Although
dehydroepiandrosterone (DHEA), DHEA sulfate (DHEAS), and testosterone (T) all decline …

For most women, the unpredictable menstrual and hormonal events of the perimenopause
follow decades of predictable cycles and hormone patterns. By a median age of 47 years …